Ligand Pharmaceuticals Incorporated
US ˙ NasdaqGM ˙ US53220K5048

SecurityLGND / Ligand Pharmaceuticals Incorporated
InstitutionDimensional Fund Advisors Lp
Latest Disclosed Ownership425,230 shares
Latest Disclosed Value $ 84,887,195
Dimensional Fund Advisors Lp reports 1.79% decrease in ownership of LGND / Ligand Pharmaceuticals Incorporated

On May 7, 2026 - Dimensional Fund Advisors Lp filed a 13F-HR form disclosing ownership of 425,230 shares of Ligand Pharmaceuticals Incorporated (US:LGND) valued at $84,897,170 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 432,992 shares of Ligand Pharmaceuticals Incorporated. This represents a change in shares of -1.79% during the quarter. The current value of the position is $99,673,912 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 425,230 -7,762 -1.79 84,887 3.69 0.0038
2026-02-12 2025-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 432,992 -90,921 -17.35 81,867 -11.78 0.0172
2025-11-12 2025-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 523,913 -180,609 -25.64 92,799 15.87 0.0199
2025-08-12 2025-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 704,522 -40,408 -5.42 80,092 2.26 0.0185
2025-05-13 2025-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 744,930 21,911 3.03 78,324 1.10 0.0195
2025-02-13 2024-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 723,019 16,003 2.26 77,470 9.48 0.0186
2024-11-07 2024-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 707,016 -1,608 -0.23 70,762 18.52 0.0172
2024-08-09 2024-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 708,624 44,543 6.71 59,707 22.99 0.0156
2024-05-10 2024-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 664,081 2,783 0.42 48,544 2.78 0.0131
2024-02-07 2023-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 661,298 46,906 7.63 47,230 28.29 0.0138
2023-11-09 2023-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 614,392 82,970 15.61 36,816 -3.92 0.0121
2023-08-09 2023-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 531,422 61,506 13.09 38,316 10.85 0.0122
2023-05-12 2023-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 469,916 11,993 2.62 34,566 115,116.67 0.0116
2023-02-09 2022-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 457,923 8,805 1.96 31 -99.92 0.0090
2022-11-10 2022-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 449,118 6,414 1.45 38,673 -2.09 0.0148
2022-08-12 2022-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 442,704 64,586 17.08 39,497 -7.15 0.0142
2022-05-13 2022-03-31 13F LIGAND PHARMACEUTICALS COM 53220K504 378,118 5,450 1.46 42,537 -26.10 0.0131
2022-02-09 2021-12-31 13F LIGAND PHARMACEUTICALS COM 53220K504 372,668 -106 -0.03 57,563 10.83 0.0174
2021-11-12 2021-09-30 13F LIGAND PHARMACEUTICALS COM 53220K504 372,774 -36,603 -8.94 51,936 -3.30 0.0167
2021-08-12 2021-06-30 13F LIGAND PHARMACEUTICALS COM 53220K504 409,377 47,120 13.01 53,709 -2.74 0.0170
2021-05-14 2021-03-31 13F LIGAND PHARMACEUTICALS COM 53220K504 362,257 -3,534 -0.97 55,224 51.80 0.0183
2021-03-08 2020-12-31 13F/A-2 LIGAND PHARMACEUTICALS COM 53220K504 365,791 -14,048 -3.70 36,380 0.48 0.0131
2021-02-11 2020-12-31 13F LIGAND PHARMACEUTICALS COM 53220K504 365,791 -14,048 36,380 13,138.5223
2020-11-12 2020-09-30 13F LIGAND PHARMACEUTICALS COM 53220K504 379,839 -2,549 -0.67 36,206 -15.35 0.0154
2020-08-13 2020-06-30 13F LIGAND PHARMACEUTICALS COM 53220K504 382,388 -79,724 -17.25 42,771 27.28 0.0188
2020-05-14 2020-03-31 13F LIGAND PHARMACEUTICALS COM 53220K504 462,112 -7,255 -1.55 33,603 -31.35 0.0175
2020-02-14 2019-12-31 13F LIGAND PHARMACEUTICALS COM 53220K504 469,367 76,224 19.39 48,950 25.09 0.0178
2019-11-12 2019-09-30 13F LIGAND PHARMACEUTICALS COM 53220K504 393,143 159,930 68.58 39,133 47.00 0.0152
2019-08-13 2019-06-30 13F LIGAND PHARMACEUTICALS COM 53220K504 233,213 21,110 9.95 26,621 -0.15 0.0103
2019-08-12 2019-03-31 13F/A-2 LIGAND PHARMACEUTICALS COM 53220K504 212,103 4,797 2.31 26,662 -5.23 0.0106
2019-05-10 2019-03-31 13F LIGAND PHARMACEUTICALS COM 53220K504 212,103 4,797 26,662
2019-02-26 2018-12-31 13F/A-1 LIGAND PHARMACEUTICALS COM 53220K504 207,306 32,096 18.32 28,132 -41.51 0.0127
2019-02-13 2018-12-31 13F LIGAND PHARMACEUTICALS COM 53220K504 207,306 32,096 28,132
2018-11-13 2018-09-30 13F LIGAND PHARMACEUTICALS COM 53220K504 175,210 -23,875 -11.99 48,093 16.60 0.0183
2018-08-10 2018-06-30 13F LIGAND PHARMACEUTICALS COM 53220K504 199,085 -23,201 -10.44 41,245 12.34 0.0164
2018-05-11 2018-03-31 13F LIGAND PHARMACEUTICALS COM 53220K504 222,286 -3,681 -1.63 36,713 18.65 0.0153
2018-02-12 2017-12-31 13F LIGAND PHARMACEUTICALS COM 53220K504 225,967 -11,163 -4.71 30,942 -4.16 0.0128
2017-11-13 2017-09-30 13F LIGAND PHARMACEUTICALS COM 53220K504 237,130 -26,466 -10.04 32,285 0.89 0.0141
2017-08-11 2017-06-30 13F LIGAND PHARMACEUTICALS COM 53220K504 263,596 -4,548 -1.70 32,001 12.76 0.0148
2017-05-12 2017-03-31 13F LIGAND PHARMACEUTICALS COM 53220K504 268,144 -189 -0.07 28,380 4.09 0.0136
2017-02-09 2016-12-31 13F LIGAND PHARMACEUTICALS COM 53220K504 268,333 -547 -0.20 27,265 -0.64 0.0136
2016-11-10 2016-09-30 13F LIGAND PHARMACEUTICALS COM 53220K504 268,880 -18,712 -6.51 27,442 -20.00 0.0148
2016-08-09 2016-06-30 13F LIGAND PHARMACEUTICALS COM 53220K504 287,592 -78,876 -21.52 34,302 -12.59 0.0197
2016-05-13 2016-03-31 13F LIGAND PHARMACEUTICALS COM 53220K504 366,468 -184,700 -33.51 39,244 -34.33 0.0235
2016-02-10 2015-12-31 13F LIGAND PHARMACEUTICALS COM 53220K504 551,168 -8,590 -1.53 59,758 24.65 0.0372
2015-11-13 2015-09-30 13F LIGAND PHARMACEUTICALS COM 53220K504 559,758 8,501 1.54 47,942 -13.81 0.0315
2015-08-14 2015-06-30 13F LIGAND PHARMACEUTICALS COM 53220K504 551,257 32,112 6.19 55,621 38.94 0.0341
2015-05-14 2015-03-31 13F LIGAND PHARMACEUTICALS COM 53220K504 519,145 84,290 19.38 40,031 73.01 0.0253
2015-02-06 2014-12-31 13F LIGAND PHARMACEUTICALS COM 53220K504 434,855 37,750 9.51 23,138 24.00 0.0152
2014-11-13 2014-09-30 13F LIGAND PHARMACEUTICALS COM 53220K504 397,105 25,667 6.91 18,660 -19.35 0.0132
2014-08-08 2014-06-30 13F LIGAND PHARMACEUTICALS COM 53220K504 371,438 150,470 68.10 23,137 55.67 0.0161
2014-05-14 2014-03-31 13F LIGAND PHARMACEUTICALS COM 53220K504 220,968 94,281 74.42 14,863 123.03 0.0111
2014-02-12 2013-12-31 13F LIGAND PHARMACEUTICALS COM 53220K504 126,687 125,836 14,786.84 6,664 17,910.81 0.0052
2013-11-13 2013-09-30 13F LIGAND PHARMACEUTICALS COM 53220K504 851 0 0.00 37 15.63 0.0000
2013-08-15 2013-06-30 13F LIGAND PHARMACEUTICALS COM 53220K504 851 851 32 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.